# NERVGEN PHARMA CORP (NGEN)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/NGEN/

- Reporting holders: 2
- Reported value: $34.4K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Paladin Partners, LLC](https://holderbook.com/funds/2141570-paladin-partners-llc/) | $19.1K | 10,000 | 0.0% | 2 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $15.3K | 8,000 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 2 | $34.4K |
| Q2 2026 | 66 | $26.7M |
| Q1 2026 | 45 | $6.4M |
| Q1 2024 | 1 | $5.0K |
| Q4 2023 | 1 | $6.0K |
| Q3 2023 | 1 | $4.0K |
| Q2 2023 | 1 | $4.0K |
| Q1 2023 | 1 | $4.0K |
| Q4 2022 | 1 | $4.0K |
| Q3 2022 | 1 | $4.0K |
| Q2 2022 | 2 | $50.0K |
| Q1 2022 | 2 | $48.0K |